TITLE

Aldosterone synthase inhibitors in hypertension: current status and future possibilities

AUTHOR(S)
Hargovan, Milan; Ferro, Albert
PUB. DATE
January 2014
SOURCE
JRSM Cardiovascular Disease;Jan-Dec2014, Vol. 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The renin-angiotensin aldosterone system is a critical mechanism for controlling blood pressure, and exerts most of its physiological effects through the action of angiotensin II. In addition to increasing blood pressure by increasing vascular resistance, angiotensin II also stimulates aldosterone secretion from the adrenal gland. Aldosterone acts to cause an increase in sodium and water reabsorption, thus elevating blood pressure. Although treatment with angiotensin converting enzyme inhibitors initially lowers circulating aldosterone, with chronic treatment aldosterone levels increase back to baseline, a phenomenon termed aldosterone escape; aldosterone blockade may therefore give added value in the treatment of hypertension. The first mineralocorticoid receptor antagonist developed was spironolactone, but its use has been severely hampered by adverse (notably oestrogenic) effects. The more recently developed mineralocorticoid receptor antagonist eplerenone exhibits a better adverse effect profile, although it is not devoid of effects similar to spironolactone. In addition, aldosterone activates non-genomic receptors that are not inhibited by either eplerenone or spironolactone. It is believed that deleterious organ remodelling is mediated by aldosterone via such non-genomic pathways. A new class of drugs, the aldosterone synthase inhibitors, is currently under development. These may offer a novel therapeutic approach for both lowering blood pressure and preventing the non-genomic effects of aldosterone. Here, we will review the cardiovascular effects of aldosterone and review the drugs available that target this hormone, with a particular focus on the aldosterone synthase inhibitors.
ACCESSION #
100219712

 

Related Articles

  • The Resurgence of Aldosterone in Hypertension and Cardiovascular Disease. Freel, E. Marie; Connell, John M. C. // Current Hypertension Reviews;2006, Vol. 2 Issue 1, p21 

    Aldosterone is a key cardiovascular hormone. Recent studies have illustrated its role in cardiac fibrosis and left ventricular hypertrophy as well as in impaired vascular reactivity. Moreover, many of these actions have been shown to be independent of its known effects on blood pressure. In a...

  • Primary Hyperaldosteronism in the Hypertensive Disease. Fardella, Carlos E.; Carvajal, Cristian A.; Mosso, Lorena M. // Current Hypertension Reviews;2006, Vol. 2 Issue 1, p33 

    Primary aldosteronism (PA) is one of the potentially curable forms of hypertension. The hypertension is secondary to aldosterone action in the kidney, reabsorbing sodium and water that increases the intravascular volume and blood pressure. PA was previously believed to account for less than 1%...

  • Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension. Bianchetti, Mario G.; Weidmann, Peter; Beretta-Piccoli, Carlo; Ferrier, Claudia // Kidney International;Apr1987, Vol. 31 Issue 4, p956 

    Blood pressure (BP), plasma electrolytes, renin, aldosterone, angiotensin 11 (AII) or catecholamines, the chronotropic effects of intravenous isoproterenol. norepinephrine (NE)or AII, the pressor responses to NE or AII, and the relationship between plasma AII and aldosterone concentrations were...

  • Collecting duct--specific knockout of endothelin-1 causes hypertension and sodium retention. Ahn, Dowhan; Yuqiang Ge; Stricklett, Peter K.; Gill, Pritmohinder; Taylor, Deborah; Hughes, Alisa K.; Yanagisawa, Masashi; Miller, Lance; Nelson, Raoul D.; Kohan, Donald E. // Journal of Clinical Investigation;Aug2004, Vol. 114 Issue 4, p504 

    In vitro studies suggest that collecting duct-derived (CD-derived) endothelin-1 (ET-1) can regulate renal Na reabsorption; however, the physiologic role of CD-derived ET-1 is unknown. Consequently, the physiologic effect of selective disruption of the ET-1 gene in the CD of mice was determined....

  • The renin-aldosterone system during normal and hypertensive pregnancy. Elsheikh, A.; Creatsas, G.; Mastorakos, G.; Milingos, S.; Loutradis, D.; Michalas, S. // Archives of Gynecology & Obstetrics;Jan2001, Vol. 264 Issue 4, p182 

    Gestational hypertension complicates approximately 5%–7% of pregnancies and it may be deleterious to both maternal and fetal health. Gestational hypertension is a multisystem disorder which always resolves itself after delivery; its primary pathology still remains incompletely clarified....

  • Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: Studies in normal subjects and patients with essential hypertension. Weidmann, Peter; Beretta-Piccoli, Carlo; Ziegler, Walter H.; Keusch, Gerald; Glück, Zeev; Reubi, François C. // Kidney International;Dec1978, Vol. 14 Issue 6, p619 

    The relative influence of sodium balance and age on plasma renin activity (PRA), aldosterone (PA), norepinephrine (NE). and epinephrine (E) levels, and urinary NE or E measured in an outpatient setting was evaluated in 90 normal subjects and 79 patients with benign essential hypertension. Ranges...

  • Effects of Sublingual Administration of Nifedipine on Arterial Pressure, Plasma Renin Activity, and Glomerular Filtration Rate in Essential Hypertension. Yurtkuran, Mustafa; Dilek, Kamil; Mustafa Güllülü; Yavuz, Mahmut; Müftüoglu, Ayça // Angiology;Sep1989, Vol. 40 Issue 9, p791 

    Effects of sublingual administration of nifedipine on systemic arterial pressure (BP), plasma renin activity (PRA), aldosteron level (AL), and serum sodium (Na) and potassium (K) levels, have been determined. A significant decrease was observed in systolic and diastolic blood pressure five...

  • Conn's Syndrome: A Diagnostic Dilemma. Case Report. Butt, Waqas Tariq; Butt, Muhammad Umer; Gauhar, Tooba Mahmud; Khawaja, Ali Azim; Afzal, Ameer; Ahmed, Ashfaq; Azim, Khawaja Muhammad // Internet Journal of Surgery;2010, Vol. 24 Issue 1, p1 

    Conn's syndrome or primary hyperaldosteronism is characterized by hypertension, hypokalemia and increased ratio of plasma aldosterone concentration (ng/dl) to plasma renin activity (ng/ml per hour). Primary aldosteronism occurs most commonly due to aldosterone producing adenoma (Conn's syndrome)...

  • What Was Normal Blood Pressure Is Now Considered Too High.  // Tufts University Health & Nutrition Letter;Jul2003, Vol. 21 Issue 5, p4 

    Reports on the introduction of the prehypertension category in the blood pressure guidelines of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure in the U.S., as of July 2003. Prevalence of prehypertension in the U.S.; Lifestyle changes...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics